I. Díaz

New insights into the mechanisms underlying vascular and cardiac effects of urocortin.

I. Díaz, T. Smani, Ignacio Díaz, 2013, Current vascular pharmacology.

Circulating miR-320a as a Predictive Biomarker for Left Ventricular Remodelling in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention

I. Díaz, T. Smani, G. Barón-Esquivias, 2020, Journal of clinical medicine.

Reprimo as a Potential Biomarker for Early Detection in Gastric Cancer

Carlos Barrientos, A. Corvalán, I. Díaz, 2008, Clinical Cancer Research.

Urotensin-II Signaling Mechanism in Rat Coronary Artery: Role of STIM1 and Orai1-Dependent Store Operated Calcium Influx in Vasoconstriction

A. Dominguez-Rodriguez, I. Díaz, T. Smani, 2012, Arteriosclerosis, thrombosis, and vascular biology.

miR-125a, miR-139 and miR-324 contribute to Urocortin protection against myocardial ischemia-reperfusion injury

A. Dominguez-Rodriguez, I. Díaz, T. Smani, 2017, Scientific Reports.

Urocortin-1 Mediated Cardioprotection Involves XIAP and CD40-Ligand Recovery: Role of EPAC2 and ERK1/2

I. Díaz, T. Smani, A. Ordóñez, 2016, PloS one.

Urocortin-2 Prevents Dysregulation of Ca2+ Homeostasis and Improves Early Cardiac Remodeling After Ischemia and Reperfusion

A. Dominguez-Rodriguez, I. Díaz, T. Smani, 2018, Front. Physiol..

Urocortin‐2 induces vasorelaxation of coronary arteries isolated from patients with heart failure

A. Dominguez-Rodriguez, I. Díaz, T. Smani, 2011, Clinical and experimental pharmacology & physiology.

Urotensin-II promotes vascular smooth muscle cell proliferation through store-operated calcium entry and EGFR transactivation.

I. Díaz, T. Smani, M. Trebak, 2013, Cardiovascular research.